ResearcherDublin City UniversityActive in the last 2 years

Silvia Giordani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9212-5067; OpenAlex author ID A5013456284. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper

Papers 1

Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs. Last author DOI 10.1016/j.jcis.2023.12.166 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michał Bartkowski · 1 shared paper, 2024 · strength 0.21
- Paper Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of ge… DOI 10.1016/j.jcis.2023.12.166 ↗
Silvia Arpicco · 1 shared paper, 2024 · strength 0.21
- Paper Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of ge… DOI 10.1016/j.jcis.2023.12.166 ↗
Valeria Bincoletto · 1 shared paper, 2024 · strength 0.21
- Paper Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of ge… DOI 10.1016/j.jcis.2023.12.166 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.